HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Costes-Martineau, V Articles by Delsol, G Search for Related Content PubMed PubMed Citation Articles by Costes-Martineau, V Articles by Delsol, G

Anaplastic lymphoma kinase (ALK) protein expressing lymphoma after liver transplantation: case report and literature review

¹ Department of Pathology, Hôpital Gui de Chauliac, 34295 Montpellier, France
² Department of Liver Transplantation, Hôpital Saint Eloi, 34295 Montpellier, France
³ Department of Pathology and UPR CNRS 2163, Hôpital Purpan, Toulouse, France

Correspondence to:
Dr V Costes-Martineau, Department of Pathology, Hôpital Gui de Chauliac, 34295 Montpellier Cedex 5, France;
v-costes_martineau{at}chu-montpellier.fr
ABSTRACT
Most post transplantation lymphoproliferative disorders (PTLDs) are Epstein-Barr virus (EBV) associated B cell proliferations. We report a case of aggressive anaplastic large cell lymphoma expressing the anaplastic lymphoma kinase (ALK) protein in a 58 year old man who had previously undergone liver transplantation. A definite diagnosis was not possible on histopathological examination. Immunostaining clearly showed a predominant population of small irregular lymphocytes, admixed with large cells strongly positive for CD30, epithelial membrane antigen, and the ALK protein. Neoplastic cells were of the T/cytotoxic phenotype. In situ hybridisation with EBV encoded early RNA probes showed only a few scattered positive non-neoplastic small lymphocytes. Polymerase chain reaction analysis of immunoglobulin and T cell receptor rearrangements was negative. The NPM–ALK fusion transcript associated with the t(2;5) translocation was detected by reverse transcription polymerase chain reaction. A review of the literature revealed 76 cases of T cell PTLD, showing a broad spectrum of morphological features and clinical behaviour. Most of these cases were EBV negative (61 of 76) and occurred after renal transplantation (48 of 76). To our knowledge, this is the first case of ALK positive lymphoma occurring in the setting of organ transplantation. This observation stresses the need for accurate immunostaining for diagnosing this rare, apparently aggressive, lymphoma in immunosuppressed patients.

Keywords: ALK+ lymphoma; immunohistochemistry; liver transplantation

Abbreviations: ALK, anaplastic lymphoma kinase; EBV, Epstein-Barr virus; HTLV, human T cell lymphotropic virus; NPM, nucleophosmin; PCR, polymerase chain reaction; PTLD, post transplantation lymphoproliferative disorders

This article has been cited by other articles:

				V Mahesha, K Joshi, V Jha, and R Nada Primary cardiac post-transplantation lymphoproliferative disorder--T cell type: a case report and review of the literature J. Clin. Pathol., April 1, 2007; 60(4): 447 - 448. [Full Text] [PDF]

				E. Jacobsen Anaplastic Large-Cell Lymphoma, T-/Null-Cell Type Oncologist, July 1, 2006; 11(7): 831 - 840. [Abstract] [Full Text] [PDF]